Tech Focus Asia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Asia.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on November 8, 2025

November 8, 2025

Histranger's Emotion AI Earns High-Level Validation in Hollywood

EIN Presswire

November 8, 2025

Ainnocence Expands the Druggable Universe: Targeting Therapeutics without Structural Data

EIN Presswire

November 8, 2025

Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

GlobeNewswire

November 8, 2025

Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025

GlobeNewswire

November 8, 2025

Clearwater Wellness Launches World-First Thermoelectric Ice Bath, with Tim Paine Joining as Founding Partner

GlobeNewswire

November 8, 2025

Louis Limited Sets New Standard for Trading Psychology With Dynamic Emotion Tracking Features

GlobeNewswire

November 8, 2025

AI Meets Digital Assets: CreditBlockchain Launches Free Cloud Trial for XRP Investors Era

GlobeNewswire

November 8, 2025

Telitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China

GlobeNewswire

November 8, 2025

Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to Treat Cardiovascular and Cardiometabolic Diseases

GlobeNewswire

November 8, 2025

Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy

GlobeNewswire

November 8, 2025

IGEL läutet neue Ära der EUC-Transformation und vertrauenswürdigen Endpunktsicherheit ein

GlobeNewswire

November 8, 2025

Judo Bio’s Megalin-STRIKERs Achieve First Demonstration of Functional Pharmacodynamic Effects from Kidney Selective Gene Silencing in Non-Human Primates

GlobeNewswire

November 8, 2025

Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025

GlobeNewswire

November 8, 2025

Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Presented at American Heart Association Scientific Sessions and Published in The Lancet

GlobeNewswire

November 8, 2025

Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations

GlobeNewswire

November 8, 2025

CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering

GlobeNewswire

November 8, 2025

BLUETTI Joins 11.11 Biggest Sale with Up to 74% Off on Lazada

EIN Presswire

November 8, 2025

Infometry Unveils New Solutions And Services Powered By Snowflake Intelligence & Agentic AI

EIN Presswire

November 8, 2025

Saudi “Emerge” Emergency and Crisis Resilience Platform Named Among the World’s Best Smart City Solutions in the 2025 Smart City Awards

GlobeNewswire

November 8, 2025

Die saudische Notfall- und Krisenresilienzplattform „Emerge“ wurde bei den Smart City Awards 2025 als eine der weltweit besten Smart-City-Lösungen ausgezeichnet

GlobeNewswire